Subscribe To
Pds biotechnology reschedules 2021 fourth quarter and full year financial results and conference call
FLORHAM PARK, N.J., March 22, 2022 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB), a clinical-stage immunotherapy company developing...
March 22, 2022, 7:30 pm
Piper comments on increased interest to invest in arcturus, 'incrementally positive' on argenx
Piper Sandler noted that Arcturus Therapeutics Holdings Inc's (NASDAQ: ARCT) recently filed 10-K mentions funding of $25 million from a "pharmaceut...
March 22, 2022, 3:58 pm
Why moderna shares are trading higher today
Moderna Inc (NASDAQ: MRNA) shares are trading higher Tuesday after the company announced two new vaccin...
March 22, 2022, 3:42 pm
Moderna expands covid-19 vaccines to treat related illnesses
Moderna said Tuesday that it would expand its COVID-19 vaccine to treat related illnesses....
March 22, 2022, 10:54 am
Fda panel to discuss fourth booster dose in april meeting
The FDA advisory committee meeting on Apr 6 is likely to give an insight into how the regulatory agency feels about the need for additional boosters o...
March 22, 2022, 10:32 am
Why novavax stock is due for a comeback soon
As Novavax has its Covid-19 vaccine authorized in multiple major world markets, NVAX stock is overdue f...
March 22, 2022, 7:40 am
Rising covid cases, talk of second booster drive moderna stock higher. will the rally continue?
Covid-19 vaccine maker Moderna stock has rallied by close to 29% over the last week (five trading days)...
March 22, 2022, 7:00 am
Moderna (mrna) up on fda filing for second covid booster jab
Moderna (MRNA) seeks the FDA's authorization for a fourth dose of its COVID vaccine in adults who alrea...
March 21, 2022, 3:48 pm
Dear mrna stock fans, mark your calendars for this potential moderna catalyst on march 24
Investors in Moderna (MRNA) stock will want to keep an eye on the company when Thursday rolls around as it prepares to discuss v...
March 21, 2022, 12:59 pm
Why novavax stock is slipping today
The uptake of Novavax's COVID-19 vaccine in Germany appears to be disappointing....
March 21, 2022, 12:07 pm
Sorrento's chimeric mrna covid-19 vaccine candidate shows preclinical action against omicron variants
Sorrento Therapeutics Inc (NASDAQ: SRNE) announced the publication of a preprint entitled "Chimeric mRNA based COVID-19 v...
March 21, 2022, 10:20 am
1 green flag for ocugen in 2022, and 1 red flag
The company's vaccine candidate recently took one step forward....
March 21, 2022, 6:00 am
Pfizer ceo: ‘we need to come with a vaccine that is lasting at least a year'
Pfizer CEO Dr. Albert Bourla sat down with Yahoo Finance's Julie Hyman at SXSW to discuss vaccine hesit...
March 19, 2022, 1:30 am
Week in review march 14-18: pfizer ceo on covid-19 vaccines, starbucks ceo kevin johnson to retire
Affirm CFO Michael Linford joins Yahoo Finance Live to discuss the buy now, pay later company's outlook amid stock volatility. Pfizer CEO Dr. Albert B...
March 19, 2022, 12:47 am
Glaxosmithkline needs positive outcome of rsv vaccine clinical trial
Do investors want to take a chance on GlaxoSmithKline PLC ( GSK , Financial) reporting positive results mid-year from the key trial of its respiratory...
March 18, 2022, 5:11 pm
What moderna and pfizer's vaccine moves say about covid's next phase
An increase in Covid-19 cases in some European countries tied to an Omicron sub-variant has raised concerns about another surge to come....
March 18, 2022, 1:57 pm
Risk of brain blood clots ‘significantly higher' after covid infection than pfizer, moderna shots, study finds
The risk of developing serious brain blood clots is 28 to 32 times higher in people with Covid than those who get v...
March 18, 2022, 12:19 pm
New patent lawsuit adds to litigation worries for moderna stock
A new set of patent lawsuits over the technology behind the messenger RNA-based Covid-19 vaccines incre...
March 18, 2022, 10:16 am
Why dynavax stock was winning this week
Several coronavirus vaccines using the company's adjuvant are advancing up the regulatory ladder....
March 18, 2022, 9:20 am
Astrazeneca ready to drop us approval attempt for covid vaccine - report
AstraZeneca PLC (LSE:AZN) is ready to drop attempts to get its Covid-19 vaccine approved in the US, acc...
March 18, 2022, 8:07 am